Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Arcion Therapeutics Inc.
DescriptionTopical formulation of lidocaine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationNeuralgia
Indication DetailsTreat post-herpetic neuralgia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today